CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The European Union on Tuesday gave marketing approval to drugmakers Roche and Trimeris to sell their HIV fusion inhibitor Fuzeon in all 15 member nations. The drug will cost $20,385 per year in Europe, slightly higher than the U.S. cost. The Food and Drug Administration approved Fuzeon for sale in the United States on March 13. Fuzeon, previously known as T-20, is the world's first HIV fusion inhibitor that works outside immune system cells to prevent HIV from attaching to and infecting the cells. All other available anti-HIV medications work to slow HIV replication inside cells already infected with the virus. Clinical trials showed Fuzeon to help lower blood-based viral loads, even among those carrying drug-resistant virus, when used as part of combination therapy. A Fuzeon follow-up product, called T-1249, is currently in development and has been shown in clinical trials to reduce viral levels in patients who have developed resistance to other anti-HIV medications, including Fuzeon. The E.U. also expanded its approval of Viread, Gilead Science's nucleotide reverse transcriptase inhibitor. The drug was approved in 2002 for treatment among HIV-positive people who've already taken other anti-HIV medications. The expanded approval allows doctors to prescribe Viread as part of first-time therapy. Viread was approved in the United States in 2001.
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
After 20 years, and after tonight, Obama will no longer be the Democrats' top star
August 20 2024 12:28 PM
Trump ally Laura Loomer goes after Lindsey Graham: ‘We all know you’re gay’
September 13 2024 2:28 PM
Melania Trump cashed six-figure check to speak to gay Republicans at Mar-a-Lago
August 16 2024 5:57 PM
These 13 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Latest Stories
Fearless + Fighting Back: Lambda Legal’s plan to protect LGBTQ+ and HIV rights
February 04 2025 6:04 PM
e.l.f. Beauty CEO defends DEI: 'Our diversity is a key competitive advantage'
February 04 2025 5:19 PM
Trump moves to abolish Education Department amid push against 'wokeness'
February 04 2025 2:50 PM
Donald Trump's DOT will prioritize areas with higher 'marriage and birth rates'
February 04 2025 1:42 PM
Kim Davis is back in court because she doesn't want to pay a gay couple
February 04 2025 12:27 PM
Amber Ruffin to headline 2025 White House Correspondents’ Dinner. But, will Trump attend?
February 04 2025 11:49 AM
Transgender author Jennifer Finney Boylan: The fight is not over
February 04 2025 11:24 AM
Rep. Sarah McBride denounces Donald Trump’s ongoing attacks on transgender people
February 04 2025 11:19 AM
Mark Robinson drops lawsuit over CNN's 'Black Nazi' report
February 04 2025 11:08 AM